[go: up one dir, main page]

GB1149640A - Amino-halopteridines and pharmaceutical compositions containing them - Google Patents

Amino-halopteridines and pharmaceutical compositions containing them

Info

Publication number
GB1149640A
GB1149640A GB4340166A GB4340166A GB1149640A GB 1149640 A GB1149640 A GB 1149640A GB 4340166 A GB4340166 A GB 4340166A GB 4340166 A GB4340166 A GB 4340166A GB 1149640 A GB1149640 A GB 1149640A
Authority
GB
United Kingdom
Prior art keywords
amino
aryl
mononuclear
substituted
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4340166A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB1149640A publication Critical patent/GB1149640A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/06Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

1,149,640. 2,4-Diaminopteridine compounds. MERCK & CO. Inc. 28 Sept., 1966 [4 Oct., 1965], No. 43401/66. Heading C2C. The invention comprises 2,4-diarnino-pteridines of the formula where Y is Cl, Br or I and X is H, Cl, Br, mercapto, hydroxy, C 1-6 aliphaticoxy, mononuclear-aryl-substituted C 1-6 aliphaticoxy, C 1-6 aliphaticthio, mononuclear-aryl-substituted C 1-6 aliphaticthio, C 1-6 aliphatic, mononuclear aryl, or mononuclear-aryl-substituted C 1-6 aliphatic, or an amino radical -N-(CH 2 ) n , where n is 4, 5 or 6 or where each of R and R<SP>1</SP>, which are the same or different, is H, C 1-6 alkoxy, C 1-6 alkyl, mononuclear aryl, or a substituted C 1-6 alkyl radical having one or more substituents taken from halogen, hydroxy, alkoxy, C 3-6 cycloalkyl, mononuclear aryl, (C 1-6 alkyl)-substituted mononuclear aryl, halogenated mononuclear aryl, amino, C 1-6 alkylamino, di(C 1-6 alkyl)amino and heterocyclics (e.g. furyl and pyridyl). The novel compounds (except those in which X is hydroxy or mercapto) are obtained by reaction of a 3- amino - 5 - X - 6 - halopyrazinonitrile with guanidine. Compounds of Formula I in which X is hydroxy or mercapto are obtained by replacing the 7-chlorine atom of the corresponding 7-chloro compound (a) by dissolving in dimethylformamide, adding sodium acetate and heating, followed by treatment with NaOH solution; or (b) by heating with a mixture of Na 2 S.H 2 O and S in ethanol which has been refluxed for 30 minutes. 3 - Amino - 5 - X - 6 - iodopyrazinonitriles are obtained by catalytic hydrogenolysis of a 3- amino-5-X-6-(chloro or bromo) - pyrazinonitrile using Pd-on-charcoal catalyst in the presence of MgO to form a 3-amino-5-X-pyrazinonitrile which is then iodinated using iodine and mercuric acetate in a solvent such as aqueous dioxane or tetrahydrofuran preferably with heating at 50-100‹ C. for 5-30 minutes. 3 - Amino - 6 - iodopyrazinonitrile is obtained by reacting methyl 3-amino-6-iodopyrazinoate with ammonium hydroxide to form 3-amino-6- iodopyrazinamide which is treated with dimethyl formamide and phosphoral chloride to give N,N - dimethyl - N<SP>1</SP> - (3 - cyano - 5 - iodo- 2-pyrazinyl) formamidine which is hydrolysed to yield the desired product. 3 - Amino - 5 - X - 6 (chloro or bromo) - pyrazinonitriles are described in Specification 1,149,639. Pharmaceutical compositions having diuretic and saluretic properties comprise a compound of Formula I above together with an inert diluent, carrier or coating in forms suitable for oral or parenteral administration.
GB4340166A 1965-10-04 1966-09-28 Amino-halopteridines and pharmaceutical compositions containing them Expired GB1149640A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49289865A 1965-10-04 1965-10-04

Publications (1)

Publication Number Publication Date
GB1149640A true GB1149640A (en) 1969-04-23

Family

ID=23958060

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4340166A Expired GB1149640A (en) 1965-10-04 1966-09-28 Amino-halopteridines and pharmaceutical compositions containing them

Country Status (9)

Country Link
BE (1) BE687730A (en)
BR (1) BR6683209D0 (en)
CH (1) CH479601A (en)
DE (1) DE1620034A1 (en)
ES (1) ES332322A1 (en)
FR (1) FR6028M (en)
GB (1) GB1149640A (en)
IL (1) IL26578A (en)
NL (1) NL6613936A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7691858B2 (en) 2006-04-25 2010-04-06 Targegen, Inc. Kinase inhibitors and methods of use thereof
US8372971B2 (en) 2004-08-25 2013-02-12 Targegen, Inc. Heterocyclic compounds and methods of use
US8481536B2 (en) 2004-04-08 2013-07-09 Targegen, Inc. Benzotriazine inhibitors of kinases

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8481536B2 (en) 2004-04-08 2013-07-09 Targegen, Inc. Benzotriazine inhibitors of kinases
US8372971B2 (en) 2004-08-25 2013-02-12 Targegen, Inc. Heterocyclic compounds and methods of use
US7691858B2 (en) 2006-04-25 2010-04-06 Targegen, Inc. Kinase inhibitors and methods of use thereof

Also Published As

Publication number Publication date
ES332322A1 (en) 1967-07-16
CH479601A (en) 1969-10-15
BR6683209D0 (en) 1973-12-26
DE1620034A1 (en) 1970-02-05
IL26578A (en) 1970-11-30
NL6613936A (en) 1967-04-05
FR6028M (en) 1968-05-13
BE687730A (en) 1967-04-03

Similar Documents

Publication Publication Date Title
GB1234058A (en)
GB1496579A (en) Cyano-pyridine derivatives
GB1466839A (en) Substituted phenylguanidines a process for their preparation and their use as medicaments
GB1335492A (en) Cyclocytidine compounds and process for making same
GB1106040A (en) Novel benzdiaz[1,4]epine derivatives and a process for the manufacture thereof
GB1149640A (en) Amino-halopteridines and pharmaceutical compositions containing them
GB1429141A (en) 1-substituted pyrazol-5-ones their production and their medicinal use
US3723498A (en) Pesticidal 1-amino-1-mercapto-2-cyano-ethene derivatives
US2980665A (en) Pyrimidines
SU517587A1 (en) Method for preparing 2-oxphenylurea derivatives
GB1490486A (en) 4-imino-1,3-diazobicyclo-(3.1.0)hexan-2-one
IL27897A (en) Preparation of pyrazinoylguanidines and pyrazinamidoguanidines
GB1353545A (en) S-triazine derivatives and their salts and process for producing them
GB1050633A (en)
GB1297299A (en)
GB1437895A (en) Thiazolylurea derivatives and process for the preparation thereof
GB1505020A (en) Substituted 2-phenylimino-thiazolines a process for their preparation and their use as ectoparasiticides
GB1251600A (en)
GB1167097A (en) Guanidine Derivatives
GB1197691A (en) Substituted Thienoimidazoles
US2710881A (en) New substituted semicarbazides
US2467893A (en) Piperazine carboxamides and method of preparing same
GB1254270A (en) Benzoxazepine derivatives
GB1023218A (en) Substituted pyrido [2,3-e]-triazine 1-oxides
GB1466829A (en) 1,4-oxathiino 2,3-c- pyrrole derivatives